Global Tracheostomy Products Market is expected to grow with the CAGR of 4.6% in the forecast period of 2020 to 2027. The years considered for study are as mentioned below.
Access Full Report @ https://www.databridgemarketresearch.com/reports/global-tracheostomy-products-market
Global tracheostomy products market is a highly consolidated market which includes specific number of key players. The market has witnessed increased strategic developments owing to favourable market scenario.
The major players dealing in global tracheostomy products market are introducing strong range of products provider along with launching new products and adopting strategic initiatives such as acquisition, agreement into the tracheostomy products market. This helped companies to maximize the sales with enhanced their product portfolio. For instance, in January 2020, Smiths Medical launched BLUselect tracheostomy tubes along with the BLUperc and BLUgriggs percutaneous tracheostomy kits and trays. These advanced products launched by the company increase its demand and sales in future.
Medtronic is the dominating player in global tracheostomy products market. The other key players existing in the tracheostomy products market includes Stening SRL, Cook, Bicakcilar Medical, TROGE MEDICAL GmbH, Henan Tuoren Medical Device Co., Ltd., Fisher & Paykel Healthcare Limited, Medis Medical (UK) Ltd, Pulmodyne, Inc., Fuji Systems, DEAS S.R.L., Sterimed Group, Angiplast, ConvaTec Group PLC, Smiths Medical (a subsidiary of Smiths Group plc), Andreas Fahl Medizintechnik – Vertrieb GmbH, Boston Medical Products Inc., TRACOE medical GmbH, Teleflex Incorporated and Well Lead Medical Co.,Ltd among others.
Medtronic is headquartered in Dublin, Ireland and was founded in 1949. The company focuses on treatment of various health conditions including cardiac devices, cranial and spine robotics, insulin pumps, surgical tools, patient monitoring systems and more by providing products in domains such as cardiovascular, diabetes among more. The company deals in different business segments such as cardiovascular and vascular group, diabetes group, minimally invasive therapies group and restorative therapies group out of which minimally invasive therapies group is the market focused segment. The company is providing products under various categories such as advanced surgical technology, cardiac rhythm, cardiovascular, diabetes, digestive & gastrointestinal, ear, nose & throat, general surgery, gynaecological, neurological, oral, maxillofacial & dental, patient monitoring, renal care, respiratory, spinal & orthopaedic, surgical navigation & imaging and urological among which the market focused products lie under respiratory category. The company is engaged in continuous strategic initiatives for expanding the market of tracheostomy products.
The company has wide presence across Asia-Pacific, Europe, Middle East and Africa, North America and South America. The company has various subsidiaries such as Medtronic Bio-Medicus, Inc. (U.S.), Medtronic China, Ltd. (U.S.), Medtronic Comercial Ltda. (Brazil), Medtronic Endonetics, Inc. (U.S.), Medtronic G.m.b.H. (Germany) among others.
Smiths Medical (a subsidiary of Smiths Group plc):
Smith’s Medical (a subsidiary of Smiths Group plc) is headquartered in Minnesota, U.S. and was founded in 1940. The company focuses on manufacturing of specialty medical devices that provides innovative and lifesaving solutions for the world’s healthcare markets by offering products in categories such as infusion therapy, vascular access, vital care and specialty products & services. The company is providing products under several categories such as airway management, drainage systems, infusion, interventional imaging, pain management, patient monitoring, peripheral IV catheters (PIVC), pressure monitoring, respiratory, sharps safety, temperature management, tracheostomy, vascular access, ventilation and veterinary among which the market focused products lie under airway management and tracheostomy category. The company is engaged in continuous development of tracheostomy products.
The company has wide presence across Europe, North America and Asia-Pacific. The company also has various subsidiary companies such as Access Scientific LLC (U.S.), Smiths Medical Instrument (Zhejiang) Co., Ltd. (China), Smiths Medical PM Inc. (U.S.), DHD Healthcare Corporation ( U.S.) and Pegasus Research Corp. (U.S.) among others.
Teleflex Incorporated is headquartered in Pennsylvania, U.S. and was incorporated in 1943. The company focuses on providing solutions in the fields of vascular and interventional access, surgical, anesthesia, cardiac care, urology, emergency medicine and respiratory care. The company is engaged in providing products under various categories such as anaesthesia, interventional cardiology/radiology, interventional urology-urolift system, military federal respiratory, surgical, urology and vascular access & teleflex medical OEM among which anaesthesia is the market focused category. The company has initiated many strategic initiatives to expand its market.
The company has wide presence across Europe, North America, South America, Middle East & Africa and Asia-Pacific. The company has various subsidiary companies such as Arrow Internacional de Chihuahua, S.A. de C.V. (Mexico), Daqing Medical Device (Tianjin) Co., Ltd. (China), Sometec Holdings SAS (France), Rüsch Austria GmbH (Austria) and Teleflex Euro LLC (Ireland) among more.
Global Tracheostomy Products Market – Industry Trends and Forecast to 2027
Middle East and Africa Tracheostomy Products Market – Industry Trends and Forecast to 2027
Asia-Pacific Tracheostomy Products Market – Industry Trends and Forecast to 2027
Europe Tracheostomy Products Market – Industry Trends and Forecast to 2027
North America Tracheostomy Products Market – Industry Trends and Forecast to 2027